Phoenix Children’s Hospital breaks ground on $15M cancer center / Phoenix Business Journal
Phoenix Children’s Hospital, which is part of the Pediatric Cancer MoonShot Consortium, breaks ground on a $15 million cancer center that’s expected to open next year.
Avnet and ASU partner on new innovation incubator to further tech startups / Phoenix Business Journal
Phoenix-based Avnet Inc. and Arizona State University have partnered to create a new innovation incubator which includes a bioscience company among its first four technology startups.
The Arizona Biospecimen Locator—an online database of tissue and organ samples developed under the purview of the Arizona Biomedical Research Commission but later discontinued—could potentially be revived.
University of Arizona College of Medicine-Phoenix graduation / Arizona Republic
A photo slideshow captures the graduation festivities of the University of Arizona College of Medicine-Phoenix held on May 9.
Billionaire doctor files IPO for personalized medicine company / Phoenix Business Journal
Dr. Patrick Soon-Shiong, who has a growing presence in the Phoenix market with ties to the Phoenix Biomedical Campus, ASU, and Phoenix Children’s Hospital, is getting ready to take his company public in a $92 million initial public offering.
Tucson researcher will lead $27 million asthma prevention study / Arizona Daily Star
A University of Arizona researcher will head a $27 million national clinical study funded by the National Institutes of Health that could lead to developing a way to prevent asthma in young children.
ASU researchers unveil $1 Zika test / KPHO/KTVK
A team of scientists that included researchers at ASU unveiled a new tool in the fight against the Zika virus—a paper-based test that costs as little as $1 per application. Read also: ASU researchers develop $1 Zika virus test
UA researchers are leading an effort to identify the genetics of diseases such as cancer, Alzheimer’s disease, and diabetes with the hope findings will lead to new treatment drugs.
Eric Miller, co-owner of the Tempe-based firm PADT, talks about the current status of Arizona’s bioscience community.